Tissue inhibitor of matrix metalloproteinase-1 role in left atrium matrix remodeling in patients with atrial febrillation
Keywords
atrial fibrillation, cardiovascular diseases, tissue inhibitor, matrix metalloproteinaseAbstract
Method: TIMP-1 was used as a marker for collagen synthesis. The study group comprised 69 people and the control group 23. Results: Patients with persistent and chronic AF had an elevated level of TIMP-1 in comparison with patients with paroxysmal AF (149.63 + 43.71 ng / ml, 155.90 + 45.86 ng / ml vs 131.51 + 36.92 ng / ml, p <0.001). The level of TIMP-1 was significantly lower in the control group compared to patients with paroxysmal, persistent and chronic AF forms (131.51 + 36.92 ng / ml, 149.63 + 43.71 ng / ml, 155.90 + 45.86 ng / ml and 103.61 + 14.96 ng / ml , P <0.001). Conclusions: The level of TIMP-1 is significantly different between healthy people and patients with AF. Moreover, these markers also differ depending on the shape of the OP. It can be assumed that the intensity of extracellular synthesis and degradation of type I collagen can be related to the severity and type of AF.Downloads
Published
2017-04-25
How to Cite
1.
GORYACHIY, A. V., GOZHENKO, A. I., LEVCHENKO, E. M., GORYACHIY, V. V., KUZNETSOVA, M. A. and ARAPU, M. I. Tissue inhibitor of matrix metalloproteinase-1 role in left atrium matrix remodeling in patients with atrial febrillation. Journal of Education, Health and Sport. Online. 25 April 2017. Vol. 7, no. 4, pp. 953-962. [Accessed 16 October 2024].
Issue
Section
Research Articles
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 133
Number of citations: 0